Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis

Autoimmunity Reviews

Volumn 16, Issue 3, 2017, Pages 308-312

  Tektonidou, Maria G ^a   Kravvariti, Evrydiki ^a   Konstantonis, George ^b   Tentolouris, Nicholas ^a   Sfikakis, Petros P ^a   Protogerou, Athanasios ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cardiovascular disease; Diabetes Mellitus; Rheumatoid Arthritis; Subclinical atherosclerosis; Systemic Lupus Erythematosus

Indexed keywords

ABATACEPT; ADALIMUMAB; ANAKINRA; AZATHIOPRINE; BELIMUMAB; CERTOLIZUMAB PEGOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; GOLIMUMAB; HEMOGLOBIN A1C; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLATE MOFETIL; RITUXIMAB;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FEMORAL ARTERY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; RHEUMATOID ARTHRITIS; RIGHT COMMON CAROTID ARTERY; RISK FACTOR; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRASOUND; ATHEROSCLEROSIS; COMPLICATION; MIDDLE AGED;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; DIABETES COMPLICATIONS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RISK FACTORS;

EID: 85012024997     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.01.009     Document Type: Article

References (34)

1. [1] Hollan, I., Meroni, P.L., Ahearn, J.M., Cohen Tervaert, J.W., Curran, S., Goodyear, C.S., et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12 (2013), 1004–1015.
2. [2] Schoenfeld, S.R., Kasturi, S., Costenbader, K.H., The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum 43 (2013), 77–95.
3. [3] Tektonidou, M.G., Wang, Z., Ward, M.M., Trends in hospitalizations due to acute coronary syndromes and stroke in patients with systemic lupus erythematosus, 1996 to 2012. Arthritis Rheum 68 (2016), 2680–2685.
4. [4] Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., Brotons, C., Catapano, A.L., et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37 (2016), 2315–2381.
5. [5] Rydén, L., Grant, P.J., Anker, S.D., Berne, C., Cosentino, F., Danchin, N., et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34 (2013), 3035–3087.
6. [6] Agca, R., Heslinga, S.C., Rollefstad, S., Heslinga, M., McInnes, I.B., Peters, M.J., et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis, Oct 3 2016, 10.1136/annrheumdis-2016-209775 [pii: annrheumdis-2016-209775].
7. [7] Wu, G.C., Liu, H.R., Leng, R.X., Li, X.P., Li, X.M., Pan, H.F., et al. Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Autoimmun Rev 15 (2016), 22–37.
8. [8] Salmon, J.E., Roman, M.J., Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 121 (2008), S3–S8.
9. [9] Vlachoyiannopoulos, P.G., Kanellopoulos, P.G., Ioannidis, J.P., Tektonidou, M.G., Mastorakou, I., Moutsopoulos, H.M., Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 42 (2003), 645–651.
10. [10] Ahmad, H.M., Sarhan, E.M., Komber, U., Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus. Rheumatol Int 34 (2014), 617–623.
11. [11] Ballocca, F., D'Ascenzo, F., Moretti, C., Omede, P., Cerrato, E., Barbero, U., et al. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Eur J Prev Cardiol 22 (2015), 1435–1441.
12. [12] Tselios, K., Sheane, B.J., Gladman, D.D., Urowitz, M.B., Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review. J Rheumatol 43 (2016), 54–65.
13. [13] Frieri, M., Stampfl, H., Systemic lupus erythematosus and atherosclerosis: review of the literature. Autoimmun Rev 15 (2016), 16–21.
14. [14] Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40, 1997, 1725.
15. [15] Zampeli, E., Protogerou, A., Stamatelopoulos, K., Fragiadaki, K., Katsiari, C.G., Kyrkou, K., et al. Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther, 14, 2012, R44.
16. [16] Protogerou, A., Zampeli, E., Tentolouris, N., Makrilakis, K., Kitas, G., Sfikakis, P.P., Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a case-control study. Ann Rheum Dis 71 (2012), 1534–1536.
17. [17] Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62 (2010), 2569–2581.
18. [18] American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33:Suppl. 1 (2010), S62–S69.
19. [19] Jellinger, P.S., Smith, D.A., Mehta, A.E., Ganda, O., Handelsman, Y., Rodbard, H.W., et al. American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 18:Suppl. 1 (2012), 1–78.
20. [20] Petri, M., Kim, M.Y., Kalunian, K.C., Grossman, J., Hahn, B.H., Sammaritano, L.R., et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353 (2005), 2250–2258.
21. [21] Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Urowitz, M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39 (1996), 363–369.
22. [22] Prevoo, M.L., van ‘t Hof, M.A., Kuper, H.H., van Leeuwen, M.A., van de Putte, L.B., van Riel, P.L., Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995), 44–48.
23. [23] Ambrosino, P., Lupoli, R., Di Minno, A., Tasso, M., Peluso, R., Di Minno, M.N., Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost 113 (2015), 916–930.
24. [24] Peters, M.J., van Halm, V.P., Voskuyl, A.E., Smulders, Y.M., Boers, M., Lems, W.F., et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 61 (2009), 1571–1579.
25. [25] Stamatelopoulos, K.S., Kitas, G.D., Papamichael, C.M., Chryssohoou, E., Kyrkou, K., Georgiopoulos, G., et al. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol 29 (2009), 1702–1708.
26. [26] Belcaro, G., Nicolaides, A.N., Ramaswami, G., Cesarone, M.R., De Sanctis, M., Incandela, L., et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). Atherosclerosis 156 (2001), 379–387.
27. [27] Ikdahl, E., Rollefstad, S., Wibetoe, G., Olsen, I.C., Berg, I.J., Hisdal, J., et al. Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 43 (2016), 1622–1630.
28. [28] Inaba, Y., Chen, J.A., Bergmann, S.R., Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 220 (2012), 128–133.
29. [29] Frerix, M., Stegbauer, J., Kreuter, A., Weiner, S.M., Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplex sonography study of carotid and femoral arteries and follow-up for cardiovascular events. Arthritis Res Ther, 16, 2014, R54.
30. [30] Protogerou, A.D., Fransen, J., Zampeli, E., Argyris, A.A., Aissopou, E., Arida, A., et al. The additive value of femoral ultrasound for subclinical atherosclerosis assessment in a single center cohort of 962 adults, including high risk patients with rheumatoid arthritis, human immunodeficiency virus infection and type 2 diabetes mellitus. PLoS One, 10, 2015, e0132307.
31. [31] Manzi, S., Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S.G., Rairie, J.E., Tracy, R.P., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42 (1999), 51–60.
32. [32] Doria, A., Shoenfeld, Y., Wu, R., Gambari, P.F., Puato, M., Ghirardello, A., et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62 (2003), 1071–1077.
33. [33] Nikpour, M., Urowitz, M.B., Ibanez, D., Harvey, P.J., Gladman, D.D., Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther, 13, 2011, R156.
34. [34] Bertsias, G., Karampli, E., Sidiropoulos, P., Gergianaki, I., Drosos, A., Sakkas, L., et al. Clinical and financial burden of active lupus in Greece: a nationwide study. Lupus 25 (2016), 1385–1394.